Cefuroxime
CEFUROXIME FOR INJECTION, USP
Approved
Approval ID
703cc338-c0b6-4a02-b8db-c27aeff181df
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Apr 8, 2020
Manufacturers
FDA
Hikma Pharmaceuticals USA Inc.
DUNS: 001230762
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cefuroxime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0143-9977
Application NumberANDA065048
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefuroxime
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateApril 8, 2020
FDA Product Classification
INGREDIENTS (1)
CEFUROXIME SODIUMActive
Quantity: 1.5 g in 1 1
Code: R8A7M9MY61
Classification: ACTIM
Cefuroxime
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0143-9979
Application NumberANDA065048
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefuroxime
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateApril 8, 2020
FDA Product Classification
INGREDIENTS (1)
CEFUROXIME SODIUMActive
Quantity: 750 mg in 1 1
Code: R8A7M9MY61
Classification: ACTIM